MBX.TO - Microbix Biosystems Inc.

Toronto - Toronto Real Time Price. Currency in CAD
Currency in CAD

Valuation Measures4

Market Cap (intraday) 57.46M
Enterprise Value 51.00M
Trailing P/E N/A
Forward P/E 40.00
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)3.50
Price/Book (mrq)2.45
Enterprise Value/Revenue 3.18
Enterprise Value/EBITDA 59.18

Trading Information

Stock Price History

Beta (5Y Monthly) 0.14
52-Week Change 3-28.57%
S&P500 52-Week Change 31.77%
52 Week High 30.5600
52 Week Low 30.3000
50-Day Moving Average 30.3896
200-Day Moving Average 30.4302

Share Statistics

Avg Vol (3 month) 341.12k
Avg Vol (10 day) 356.21k
Shares Outstanding 5138.25M
Implied Shares Outstanding 6N/A
Float 8118.05M
% Held by Insiders 113.52%
% Held by Institutions 10.91%
Shares Short (May 14, 2023) 410.98k
Short Ratio (May 14, 2023) 40.64
Short % of Float (May 14, 2023) 4N/A
Short % of Shares Outstanding (May 14, 2023) 40.01%
Shares Short (prior month Apr 13, 2023) 420.26k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4Sept 01, 1999
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Sept 29, 2022
Most Recent Quarter (mrq)Mar 30, 2023


Profit Margin -6.81%
Operating Margin (ttm)-3.28%

Management Effectiveness

Return on Assets (ttm)-1.00%
Return on Equity (ttm)-4.63%

Income Statement

Revenue (ttm)16.06M
Revenue Per Share (ttm)0.12
Quarterly Revenue Growth (yoy)-13.60%
Gross Profit (ttm)11.12M
EBITDA 164.71k
Net Income Avi to Common (ttm)-1.09M
Diluted EPS (ttm)-0.0100
Quarterly Earnings Growth (yoy)-95.70%

Balance Sheet

Total Cash (mrq)11.72M
Total Cash Per Share (mrq)0.09
Total Debt (mrq)6.54M
Total Debt/Equity (mrq)28.00
Current Ratio (mrq)6.29
Book Value Per Share (mrq)0.17

Cash Flow Statement

Operating Cash Flow (ttm)1.09M
Levered Free Cash Flow (ttm)-165.97k